Healthequity (HQY) Net Equity Issued and Repurchased (2019 - 2022)

Healthequity has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at -$2000.0 in Q1 2022.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$2000.0 in Q1 2022; TTM through Oct 2022 was -$2000.0, a 100.0% decrease from a year earlier, with the FY2022 full-year figure at $456.6 million, up 59.23% from the prior year.
• Net Equity Issued and Repurchased was -$2000.0 for Q1 2022 at Healthequity, down from $456.6 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $456.6 million in Q2 2021, with the low at -$539000.0 in Q4 2020.
• Average Net Equity Issued and Repurchased over 4 years is $148.6 million, with a median of -$2000.0 recorded in 2022.
• The largest YoY upside for Net Equity Issued and Repurchased was 39.64% in 2020 against a maximum downside of 39.64% in 2020.
• Over 4 years, Net Equity Issued and Repurchased stood at -$386000.0 in 2019, then sank by 39.64% to -$539000.0 in 2020, then jumped by 84820.22% to $456.6 million in 2021, then slumped by 100.0% to -$2000.0 in 2022.
• The last three Net Equity Issued and Repurchased figures came in at -$2000.0 (Q1 2022), $456.6 million (Q2 2021), and -$539000.0 (Q4 2020), per Business Quant data.